ArticleFrontiers in psychiatry2026
The SAFE-study: comparative treatment effect, side effect and health evaluation of allopathic versus ayurvedic treatments for major depressive disorder: a naturalistic real-world study.
Article in Frontiers in psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Major Depressive Disorder (MDD) is a prevalent mental health condition with diverse treatment modalities. There is an unmet need in the treatment of major psychiatric disorders such as depression and naturalistic treatment options which are desirable particularly for chronic and severe courses of mental illness. In addition, there is an evidence gap for naturalistic treatment options for depression. This study compares the treatment effects and side effects of allopathic and ayurvedic treatments for MDD within a real-world setting. Allopathic approaches typically involve antidepressants and psychotherapy, while ayurvedic treatments may encompass herbal remedies, panchakarma, manual therapies, dietary modifications, yoga, meditation and lifestyle interventions. Methods: This six-month, naturalistic observational study will involve 105 adult participants (18-65 years) diagnosed with MDD according to DSM-5 criteria. Participants will be categorized to one of three groups: allopathic-only treatment (n=35), ayurvedic-only treatment (n=35), or a combination of both (n=35). Depressive symptom severity will be assessed as primary endpoint using primarily the MDRS, and secondarily HAMD and PHQ-9 scales at baseline, every 2 weeks until week 8, followed by monthly assessments until months 6. Secondary outcomes will exploratively include side effects (UKU, GASE, MARS), quality of life and daily functioning (WHOQoL-BREF, GAF, FAST) as well as general health measures (e.g. lab tests). Results: The study will compare changes in primary and secondary outcome measures across the three treatment groups over time (baseline vs. week 8, month 3 and month 6) using appropriate statistical models for longitudinal data (e.g., repeated measures ANOVA, mixed-effects models. Conclusions: This study will provide valuable real-world evidence on the comparative treatment effects and side effects of allopathic and ayurvedic treatments for MDD, informing clinical practice and future research directions in this area. Findings will contribute to a more nuanced understanding of treatment options for individuals with MDD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.